BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 33620642)

  • 61. [Intraductal papillary mucinous neoplasm of the pancreas, IPMN].
    Sirén J
    Duodecim; 2013; 129(6):591-8. PubMed ID: 23614224
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A comparison between intraductal papillary neoplasms of the biliary tract (BT-IPMNs) and intraductal papillary mucinous neoplasms of the pancreas (P-IPMNs) reveals distinct clinical manifestations and outcomes.
    Minagawa N; Sato N; Mori Y; Tamura T; Higure A; Yamaguchi K
    Eur J Surg Oncol; 2013 Jun; 39(6):554-8. PubMed ID: 23506840
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Resection of main duct and mixed type IPMN ≥5 mm].
    Ceyhan GO; Scheufele F; Friess H
    Chirurg; 2017 Nov; 88(11):913-917. PubMed ID: 28842734
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Nomogram to predict malignancy in branch duct type intraductal papillary mucinous neoplasms.
    Xu Y; Xie C; Gao Z; Zhang M; Zhan M
    Medicine (Baltimore); 2022 Sep; 101(38):e30627. PubMed ID: 36197166
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The validity of the surgical indication for intraductal papillary mucinous neoplasm of the pancreas advocated by the 2017 revised International Association of Pancreatology consensus guidelines.
    Watanabe Y; Endo S; Nishihara K; Ueda K; Mine M; Tamiya S; Nakano T; Tanaka M
    Surg Today; 2018 Nov; 48(11):1011-1019. PubMed ID: 29961172
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Validation of the 2012 Fukuoka Consensus Guideline for Intraductal Papillary Mucinous Neoplasm of the Pancreas From a Single Institution Experience.
    Yu S; Takasu N; Watanabe T; Fukumoto T; Okazaki S; Tezuka K; Sugawara S; Hirai I; Kimura W
    Pancreas; 2017 Aug; 46(7):936-942. PubMed ID: 28697135
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Oncocytic-type intraductal papillary mucinous neoplasms: a unique malignant pancreatic tumor with good long-term prognosis.
    Marchegiani G; Mino-Kenudson M; Ferrone CR; Warshaw AL; Lillemoe KD; Fernández-del Castillo C
    J Am Coll Surg; 2015 May; 220(5):839-44. PubMed ID: 25840549
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Predictors of malignancy in intraductal papillary mucinous neoplasm of the pancreas: analysis of 310 pancreatic resection patients at multiple high-volume centers.
    Shimizu Y; Yamaue H; Maguchi H; Yamao K; Hirono S; Osanai M; Hijioka S; Hosoda W; Nakamura Y; Shinohara T; Yanagisawa A
    Pancreas; 2013 Jul; 42(5):883-8. PubMed ID: 23508017
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Implications of imaging criteria for the management and treatment of intraductal papillary mucinous neoplasms - benign versus malignant findings.
    Walter TC; Steffen IG; Stelter LH; Maurer MH; Bahra M; Faber W; Klein F; Bläker H; Hamm B; Denecke T; Grieser C
    Eur Radiol; 2015 May; 25(5):1329-38. PubMed ID: 25433414
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Intraductal Papillary Mucinous Neoplasms of the Pancreas: Correlation of Helical Computed Tomography (CT) Features With Pathologic Findings.
    Xu W; Liu X; Zhang J; Yang L
    Acad Radiol; 2017 May; 24(5):609-614. PubMed ID: 28153575
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Preoperative predictors of malignancy in pancreatic intraductal papillary mucinous neoplasms.
    Wiesenauer CA; Schmidt CM; Cummings OW; Yiannoutsos CT; Howard TJ; Wiebke EA; Goulet RJ; McHenry L; Sherman S; Lehman GA; Cramer H; Madura JA
    Arch Surg; 2003 Jun; 138(6):610-7; discussion 617-8. PubMed ID: 12799331
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Intraductal papillary mucinous neoplasms of the pancreas: performance of pancreatic fluid analysis for positive diagnosis and the prediction of malignancy.
    Maire F; Voitot H; Aubert A; Palazzo L; O'Toole D; Couvelard A; Levy P; Vidaud M; Sauvanet A; Ruszniewski P; Hammel P
    Am J Gastroenterol; 2008 Nov; 103(11):2871-7. PubMed ID: 18775021
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Development of ductal carcinoma of the pancreas during follow-up of branch duct intraductal papillary mucinous neoplasm of the pancreas.
    Uehara H; Nakaizumi A; Ishikawa O; Iishi H; Tatsumi K; Takakura R; Ishida T; Takano Y; Tanaka S; Takenaka A
    Gut; 2008 Nov; 57(11):1561-5. PubMed ID: 18477671
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Intraductal papillary mucinous neoplasm: clinical surveillance and management decisions.
    Chin JY; Pitman MB; Hong TS
    Semin Radiat Oncol; 2014 Apr; 24(2):77-84. PubMed ID: 24635864
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Dynamics of Fukuoka Criteria and Patient Management in Pancreatic Intraductal Papillary Mucinous Neoplasms (IPMNs) During Follow-Up.
    Schellhaas B; Vitali F; Wildner D; Görtz RS; Pfeifer L; Konturek PC; Neurath MF; Strobel D
    Med Sci Monit; 2017 Mar; 23():1483-1492. PubMed ID: 28348359
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Pancreatic tumor:progress in diagnosis and treatment. Topics: II. Intraductal papillary mucinous neoplasm of the pancreas (IPMN)/mucinous cystic neoplasm(MCN); 5. Management and diagnosis and therapeutic strategies for intraductal papillary mucinous neoplasm of the pancrea : IPMN].
    Kimura W; Takasu N; Murayama S
    Nihon Naika Gakkai Zasshi; 2012 Jan; 101(1):79-92. PubMed ID: 22413465
    [No Abstract]   [Full Text] [Related]  

  • 77. [Evaluation of intraductal papillary mucinous neoplasms of the pancreas on MDCT and MRI].
    Wang D; Zhou J; Zheng S; Xia J; Hu H
    Zhonghua Zhong Liu Za Zhi; 2014 Sep; 36(9):682-7. PubMed ID: 25564059
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Patterns of Recurrence After Resection of IPMN: Who, When, and How?
    Marchegiani G; Mino-Kenudson M; Ferrone CR; Morales-Oyarvide V; Warshaw AL; Lillemoe KD; Castillo CF
    Ann Surg; 2015 Dec; 262(6):1108-14. PubMed ID: 25793719
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Usefulness of septal thickness measurement on endoscopic ultrasound as a predictor of malignancy of branched-duct and mixed-type intraductal papillary mucinous neoplasm of the pancreas.
    Iwaya H; Hijioka S; Mizuno N; Kuwahara T; Okuno N; Tajika M; Tanaka T; Ishihara M; Hirayama Y; Onishi S; Ito A; Kuraoka N; Matsumoto S; Polmanee P; Shimizu Y; Yatabe Y; Niwa Y; Tamada K; Ido A; Hara K
    Dig Endosc; 2019 Nov; 31(6):672-681. PubMed ID: 30920028
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Differential diagnosis of benign or malignant intraductal papillary mucinous neoplasm of the pancreas by multidetector row helical computed tomography: evaluation of predictive factors by logistic regression analysis.
    Takeshita K; Kutomi K; Takada K; Haruyama T; Fukushima J; Aida R; Takada T; Furui S
    J Comput Assist Tomogr; 2008; 32(2):191-7. PubMed ID: 18379300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.